nach oben

Current Diabetes Reports

Erschienen in:

01.08.2015 | Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (E Mayer-Davis and C Shay, Section Editors)

Early-Life Exposure to Substance Abuse and Risk of Type 2 Diabetes in Adulthood

verfasst von: A. M. Vaiserman

Erschienen in: Current Diabetes Reports | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

Type 2 diabetes (T2D) is a chronic non-communicable disease that is driven by insulin resistance as a result of increasing obesity and decreasing activity levels that occur with increasing age. This disease generally develops after the age of 40, but it is now increasingly diagnosed in children and young adults. Increasing evidence, however, suggests that T2D can originate during early development. It has been repeatedly found that malnutrition during the gestational period can result in intrauterine growth restriction and low birth weight, which in combination with postnatal catch-up growth may subsequently lead to the development of T2D. There is ample evidence that T2D may also be programmed by maternal substance abuse (the harmful use of psychoactive substances such as illicit drugs or alcohol) during pregnancy and/or lactation. The research activity in this field is currently mainly focused on the childhood health problems following prenatal exposures to substance abuse. The delayed programming effects on adult-onset disorders, including metabolic syndrome and T2D, however, have been reported only rarely. This review provides animal and human evidence that early-life exposure to substance abuse, including alcohol, nicotine, and cocaine, may program not only childhood health outcomes but also life-long metabolic health status, including risk of T2D and related conditions.

Wilmot E, Idris I. Early onset type 2 diabetes: risk factors, clinical impact and management. Ther Adv Chronic Dis. 2014;5(6):234–44.PubMedCentralPubMedCrossRef

Vaag A, Brøns C, Gillberg L, Hansen NS, Hjort L, Arora GP, et al. Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes. Acta Obstet Gynecol Scand. 2014;93(11):1099–108.PubMedCrossRef

Inadera H. Developmental origins of obesity and type 2 diabetes: molecular aspects and role of chemicals. Environ Health Prev Med. 2013;18(3):185–97.PubMedCentralPubMedCrossRef

Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A. Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol. 2007;165(8):849–57.PubMedCrossRef

Narkowicz S, Płotka J, Polkowska Ż, Biziuk M, Namieśnik J. Prenatal exposure to substance of abuse: a worldwide problem. Environ Int. 2013;54:141–63.PubMedCrossRef

Sithisarn T, Granger DT, Bada HS. Consequences of prenatal substance use. Int J Adolesc Med Health. 2012;24(2):105–12.PubMedCrossRef

7.•

Behnke M, Smith VC, Committee on Substance Abuse, Committee on Fetus and Newborn. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics. 2013;131(3):e1009–24. This review provides information on the short- and long-term effects of the most common drugs involved in prenatal exposure: alcohol, nicotine, cocaine, opiates, marijuana, and methamphetamine.PubMedCrossRef

Somm E, Schwitzgebel VM, Vauthay DM, Aubert ML, Hüppi PS. Prenatal nicotine exposure and the programming of metabolic and cardiovascular disorders. Mol Cell Endocrinol. 2009;304:69–77.PubMedCrossRef

Milnerowicz-Nabzdyk E, Bizoń A. Effect of cigarette smoking on vascular flows in pregnancies complicated by intrauterine growth restriction. Reprod Toxicol. 2014;50:27–35.PubMedCrossRef

10.••

Cupul-Uicab LA, Skjaerven R, Haug K, Melve KK, Engel SM, Longnecker MP. In utero exposure to maternal tobacco smoke and subsequent obesity, hypertension, and gestational diabetes among women in the MoBa cohort. Environ Health Perspect. 2012;120:355–60. This study shows that exposure to nicotine in utero is associated with hypertension, obesity, and gestational diabetes mellitus in adult women.PubMedCentralPubMedCrossRef

11.

Bruin JE, Gerstein HC, Holloway AC. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci. 2010;116:364–74.PubMedCentralPubMedCrossRef

12.

Freitas AL, Abreu-Villaça Y, Passos MC, Lisboa PC. Neonatal nicotine exposure causes insulin and leptin resistance and inhibits hypothalamic leptin signaling in adult rat offspring. J Endocrinol. 2010;206:55–63.CrossRef

13.

Lisboa PC, de Oliveira E, de Moura EG. Obesity and endocrine dysfunction programmed by maternal smoking in pregnancy and lactation. Front Physiol. 2012;3:437.PubMedCentralPubMedCrossRef

14.

Holloway AC, Cuu DQ, Morrison KM, Gerstein HC, Tarnopolsky MA. Transgenerational effects of fetal and neonatal exposure to nicotine. Endocrine. 2007;31:254–9.PubMedCrossRef

15.

Rhee KE, Phelan S, McCaffery J. Early determinants of obesity: genetic, epigenetic, and in utero influences. Int J Pediatr. 2012;2012:9.CrossRef

16.

Alexander BT, Henry Dasinger J, Intapad S. Effect of low birth weight on women’s health. Clin Ther. 2014;36(12):1913–23.PubMedCrossRef

17.

Tanvig M. Offspring body size and metabolic profile—effects of lifestyle intervention in obese pregnant women. Dan Med J. 2014;61(7):B4893.PubMed

18.

Von K, Toschke A, Koletzko B, Slikker W. Maternal smoking during pregnancy and childhood obesity. Am J Epidemiol. 2002;156:954–61.CrossRef

19.

Wideroe M, Vik T, Jacobsen G, Bakketeig L. Does maternal smoking during pregnancy cause childhood overweight? Paediatr Perinat Epidemiol. 2003;17:171–9.PubMedCrossRef

20.

Jaddoe VW, de Ridder MA, van den Elzen AP, Hofman A, Uiterwaal CS, Witteman JC. Maternal smoking in pregnancy is associated with cholesterol development in the offspring: a 27-years follow-up study. Atherosclerosis. 2008;196:42–8.PubMedCrossRef

21.

Oken E, Levitan EB, Gillman MW. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes (Lond). 2008;32(2):201–10.CrossRef

22.

Power C, Jefferis BJ. Fetal environment and subsequent obesity: a study of maternal smoking. Int J Epidemiol. 2002;31 Suppl 2:413–9.PubMedCrossRef

23.

Thomas C, Hypponen E, Power C. Prenatal exposures and glucose metabolism in adulthood: are effects mediated through birth weight and adiposity? Diabetes Care. 2007;30:918–24.PubMedCrossRef

24.

Power C, Atherton K, Thomas C. Maternal smoking in pregnancy, adult adiposity and other risk factors for cardiovascular disease. Atherosclerosis. 2010;211:643–8.PubMedCrossRef

25.

Chiolero A, Kaufman JS. Metabolic mediators of body-mass index and cardiovascular risk. Lancet. 2014;383(9934):2042.PubMedCrossRef

26.

Geerts CC, Bots ML, Grobbee DE, Uiterwaal CS. Parental smoking and vascular damage in young adult offspring: is early life exposure critical? The atherosclerosis risk in young adults study. Arterioscler Thromb Vasc Biol. 2008;28:2296–302.PubMedCrossRef

27.••

Montgomery SM, Ekbom A. Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. Br Med J. 2002;324:26–7. The hypothesis that maternal smoking during pregnancy increases both the risk of early onset type 2 diabetes and non-diabetic obesity in offspring was tested.CrossRef

28.•

Mattsson K, Källén K, Longnecker MP, Rignell-Hydbom A, Rylander L. Maternal smoking during pregnancy and daughters’ risk of gestational diabetes and obesity. Diabetologia. 2013;56(8):1689–95. This study provides direct evidence that women prenatally exposed to nicotine are at higher risk of developing gestational diabetes and obesity.PubMedCentralPubMedCrossRef

29.

Harris HR, Willett WC, Michels KB. Parental smoking during pregnancy and risk of overweight and obesity in the daughter. Int J Obes (Lond). 2013;37(10):1356–63.CrossRef

30.

Lajous M, Tondeur L, Fagherazzi G, de Lauzon-Guillain B, Boutron-Ruaualt MC, Clavel-Chapelon F. Childhood and adult secondhand smoke and type 2 diabetes in women. Diabetes Care. 2013;36(9):2720–5.PubMedCentralPubMedCrossRef

31.

Pietraszek A, Gregersen S, Hermansen K. Alcohol and type 2 diabetes. A review. Nutr Metab Cardiovasc Dis. 2010;20(5):366–75.PubMedCrossRef

32.

Weinberg J, Sliwowska JH, Lan N, Hellemans KG. Prenatal alcohol exposure: foetal programming, the hypothalamic-pituitary-adrenal axis and sex differences in outcome. J Neuroendocrinol. 2008;20:470–88.PubMedCrossRef

33.

Dörrie N, Föcker M, Freunscht I, Hebebrand J. Fetal alcohol spectrum disorders. Eur Child Adolesc Psychiatry. 2014;23(10):863–75.PubMedCrossRef

34.

Pruett D, Waterman EH, Caughey AB. Fetal alcohol exposure: consequences, diagnosis, and treatment. Obstet Gynecol Surv. 2013;68(1):62–9.PubMedCrossRef

35.

Vaiserman AM. Long-term health consequences of early-life exposure to substance abuse: an epigenetic perspective. J DOHaD. 2013;4:269–79.

36.

Breese CR, D’Costa A, Ingram RL, et al. Long-term suppression of insulin-like growth factor-1 in rats after in utero ethanol exposure: relationship to somatic growth. J Pharmacol Exp Ther. 1993;264 Suppl 1:448–56.PubMed

37.

Schneider HJ, Friedrich N, Klotsche J, Schipf S, Nauck M, Völzke H, et al. Prediction of incident diabetes mellitus by baseline IGF1 levels. Eur J Endocrinol. 2011;164(2):223–9.PubMedCrossRef

38.

Pennington JS, Shuvaeva TI, Pennington SN. Maternal dietary ethanol consumption is associated with hypertriglyceridemia in adult rat offspring. Alcohol Clin Exp Res. 2002;26(6):848–55.PubMedCrossRef

39.

Minuk GY, Meyers AF, Legare DJ, Sadri P, Lautt WW. Fetal exposure to alcohol results in adult insulin resistance in the rat. Proc West Pharmacol Soc. 1998;41:39–40.PubMed

40.

Elton CW, Pennington JS, Lynch SA, Carver FM, Pennington SN. Insulin resistance in adult rat offspring associated with maternal dietary fat and alcohol consumption. J Endocrinol. 2002;173(1):63–71.PubMedCrossRef

41.

Chen L, Nyomba BL. Effects of prenatal alcohol exposure on glucose tolerance in the rat offspring. Metabolism. 2003;52(4):454–62.PubMedCrossRef

42.

Chen L, Nyomba BL. Whole body insulin resistance in rat offspring of mothers consuming alcohol during pregnancy or lactation: comparing prenatal and postnatal exposure. J Appl Physiol (1985). 2004;96(1):167–72.CrossRef

43.

Yao XH, Grégoire Nyomba BL. Abnormal glucose homeostasis in adult female rat offspring after intrauterine ethanol exposure. Am J Physiol Regul Integr Comp Physiol. 2007;292(5):R1926–33.PubMedCrossRef

44.

Yao XH, Chen L, Nyomba BL. Adult rats prenatally exposed to ethanol have increased gluconeogenesis and impaired insulin response of hepatic gluconeogenic genes. J Appl Physiol. 2006;100(2):642–8.PubMedCrossRef

45.••

Xia LP, Shen L, Kou H, Zhang BJ, Zhang L, Wu Y, et al. Prenatal ethanol exposure enhances the susceptibility to metabolic syndrome in offspring rats by HPA axis-associated neuroendocrine metabolic programming. Toxicol Lett. 2014;226(1):98–105. This study demonstrated that prenatal ethanol exposure induces increased susceptibility to adult metabolic syndrome in male rat offspring fed with high-fat diet.PubMedCrossRef

46.

Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr Rev. 2013;34(1):84–129.PubMedCrossRef

47.

Shen L, Liu Z, Gong J, Zhang L, Wang L, Magdalou J, et al. Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats. Toxicol Appl Pharmacol. 2014;274(2):263–73.PubMedCrossRef

48.

Harper KM, Tunc-Ozcan E, Graf EN, Redei EE. Intergenerational effects of prenatal ethanol on glucose tolerance and insulin response. Physiol Genomics. 2014;46(5):159–68.PubMedCentralPubMedCrossRef

49.

Dobson CC, Mongillo DL, Brien DC, Stepita R, Poklewska-Koziell M, Winterborn A, et al. Chronic prenatal ethanol exposure increases adiposity and disrupts pancreatic morphology in adult guinea pig offspring. Nutr Diabetes. 2012;2:e57.PubMedCentralPubMedCrossRef

50.

Dobson CC, Thevasundaram K, Mongillo DL, Winterborn A, Holloway AC, Brien JF, et al. Chronic prenatal ethanol exposure alters expression of central and peripheral insulin signaling molecules in adult guinea pig offspring. Alcohol. 2014;48(7):687–93.PubMedCrossRef

51.

Bauldry S, Shanahan MJ, Boardman JD, Miech RA, Macmillan R. A life course model of self-rated health through adolescence and young adulthood. Soc Sci Med. 2012;75(7):1311–20.PubMedCentralPubMedCrossRef

52.

SAMHSA (Substance Abuse and Mental Health Services Administration). Results from the 2010 national survey on drug use and health: summary of national findings. Office of Applied Studies, NSDUH Series H-41, Rockville, Md, USA, 2011.

53.

Plessinger MA, Woods Jr JR. Cocaine in pregnancy. Recent data on maternal and fetal risks. Obstet Gynecol Clin N Am. 1998;25(1):99–118.CrossRef

54.

Cressman AM, Natekar A, Kim E, Koren G, Bozzo P. Cocaine abuse during pregnancy. J Obstet Gynaecol Can. 2014;36(7):628–31.PubMed

55.

Lipshultz SE, Frassica JJ, Orav J. Cardiovascular abnormalities in infants prenatally exposed to cocaine. J Pediatr. 1991;118:44–51.PubMedCrossRef

56.

Messiah SE, Lipshultz SE, Miller TL, Accornero VH, Bandstra ES. Assessing latent effects of prenatal cocaine exposure on growth and risk of cardiometabolic disease in late adolescence: design and methods. Int J Pediatr. 2012;2012:467918.PubMedCentralPubMed

57.

Messiah SE, Miller TL, Lipshultz SE, Bandstra ES. Potential latent effects of prenatal cocaine exposure on growth and the risk of cardiovascular and metabolic disease in childhood. Prog Pediatr Cardiol. 2011;31(1):59–65.PubMedCentralPubMedCrossRef

58.

Shankaran S, Bann CM, Bauer CR, Lester BM, Bada HS, Das A, et al. Prenatal cocaine exposure and BMI and blood pressure at 9 years of age. J Hypertens. 2010;28(6):1166–75.PubMedCentralPubMed

59.

LaGasse LL, Gaskins RB, Bada HS, Shankaran S, Liu J, Lester BM, et al. Prenatal cocaine exposure and childhood obesity at nine years. Neurotoxicol Teratol. 2011;33(2):188–97.PubMedCentralPubMedCrossRef

60.

Ganapathy V, Prasad PD, Ganapathy ME, Leibach FH. Drugs of abuse and placental transport. Adv Drug Deliv Rev. 1999;38(1):99–110.PubMedCrossRef

61.

Suzuki K, Minei LJ, Johnson EE. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol. 1980;136(8):1009–13.PubMed

62.

Aliyu MH, Wilson RE, Zoorob R, Brown K, Alio AP, Clayton H, et al. Prenatal alcohol consumption and fetal growth restriction: potentiation effect by concomitant smoking. Nicotine Tob Res. 2009;11(1):36–43.PubMedCrossRef

63.

Hayatbakhsh MR, Flenady VJ, Gibbons KS, Kingsbury AM, Hurrion E, Mamun AA, et al. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res. 2012;71(2):215–9.PubMedCrossRef

64.

Liu AJ, Sithamparanathan S, Jones MP, Cook CM, Nanan R. Growth restriction in pregnancies of opioid-dependent mothers. Arch Dis Child Fetal Neonatal Ed. 2010;95(4):F258–62.PubMedCrossRef

65.

Huber G, Seelbach-Göbel B. Substance abuse and pregnancy from an obstetric point of view. Z Geburtshilfe Neonatol. 2014;218(4):142–8.PubMedCrossRef

66.

Ross LJ, Wilson M, Banks M, Rezannah F, Daglish M. Prevalence of malnutrition and nutritional risk factors in patients undergoing alcohol and drug treatment. Nutrition. 2012;28(7-8):738–43.PubMedCrossRef

67.

Santolaria F, Gonzalez-Reimers E. Alcohol and nutrition: an integrated perspective. In: Watson RR, Preedy VR, editors. Nutrition and alcohol: linking nutrient interactions and dietary intake. Boca Raton: CRC Press; 2004. p. 3–17.

68.

Zoli M, Picciotto MR. Nicotinic regulation of energy homeostasis. Nicotine Tob Res. 2012;14(11):1270–90.PubMedCentralPubMedCrossRef

69.

Ersche KD, Stochl J, Woodward JM, Fletcher PC. The skinny on cocaine: insights into eating behavior and body weight in cocaine-dependent men. Appetite. 2013;71:75–80.PubMedCentralPubMedCrossRef

70.

Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ. 2012;345:e4439.PubMedCentralPubMedCrossRef

71.

Sofuoglu M, Dudish-Poulsen S, Poling J, Mooney M, Hatsukami DK. The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users. Addict Behav. 2005;30(6):1125–34.PubMedCrossRef

72.

Cocores JA, Gold MS. The Salted Food Addiction Hypothesis may explain overeating and the obesity epidemic. Med Hypotheses. 2009;73(6):892–9.PubMedCrossRef

73.

Vik T, Jacobsen G, Vatten L, Bakketeig LS. Pre- and post-natal growth in children of women who smoked in pregnancy. Early Hum Dev. 1996;45:245–55.PubMedCrossRef

74.

Ross MG, Desai M. Developmental programming of offspring obesity, adipogenesis, and appetite. Clin Obstet Gynecol. 2013;56(3):529–36.PubMedCentralPubMedCrossRef

75.

Hanson MA, Gluckman PD. Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiol Rev. 2014;94(4):1027–76.PubMedCrossRef

Titel: Early-Life Exposure to Substance Abuse and Risk of Type 2 Diabetes in Adulthood
verfasst von: A. M. Vaiserman
Publikationsdatum: 01.08.2015
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 8/2015
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-015-0624-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2015

Diabetes Among Refugee Populations: What Newly Arriving Refugees Can Learn From Resettled Cambodians

Type 2 Diabetes in Children and Adolescents on Atypical Antipsychotics

Weight Loss Interventions and Progression of Diabetic Kidney Disease

Health Effects of Fructose and Fructose-Containing Caloric Sweeteners: Where Do We Stand 10 Years After the Initial Whistle Blowings?

The Development, Validation, and Utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS)